NRIXHealthcareMid-Cap
Nurix Therapeutics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Nurix Therapeutics, Inc. (NRIX), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are NRIX insiders buying or selling?
Nurix Therapeutics, Inc. insiders reported 0 open-market buys ($0) and 137 sells ($12.8M) across 137 Form 4 filings — a net selling position of $12.8M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 2, 2026)
Total Form 4 filings
137
SEC EDGAR
Insider filers
5
Insider buys (0)
$0
Insider sells (137)
$12.8M
Insider sentiment
Net sellingNet insider flow of $12.8M in net selling.
Recent NRIX insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 2, 2026 | Christine Ring | Chief Legal Officer | Sale | 11.0K | $23.56 | $259.4K |
| Jun 25, 2026 | Gwenn Hansen | Chief Scientific Officer | Sale | 5.4K | $20.00 | $107.9K |
| Jun 25, 2026 | Christine Ring | Chief Legal Officer | Sale | 28.9K | $20.06 | $580.5K |
| Jun 2, 2026 | Christine Ring | Chief Legal Officer | Sale | 8.1K | $16.60 | $135.3K |
| May 5, 2026 | Houte Hans Van | Chief Financial Officer | Sale | 14.1K | $16.60 | $233.3K |
| May 4, 2026 | Christine Ring | Chief Legal Officer | Sale | 8.1K | $16.96 | $138.2K |
| May 1, 2026 | Christine Ring | Chief Legal Officer | Sale | 5.4K | $16.76 | $90.4K |
| Apr 30, 2026 | Houte Hans Van | Chief Financial Officer | Sale | 2.4K | $16.65 | $39.7K |
| Apr 30, 2026 | Christine Ring | Chief Legal Officer | Sale | 3.2K | $16.65 | $53.5K |
| Apr 30, 2026 | Gwenn Hansen | Chief Scientific Officer | Sale | 3.2K | $16.65 | $53.5K |
| Apr 2, 2026 | Christine Ring | Chief Legal Officer | Sale | 8.1K | $15.24 | $124.1K |
| Mar 3, 2026 | Christine Ring | Chief Legal Officer | Sale | 8.1K | $15.44 | $125.8K |
| Feb 10, 2026 | Christine Ring | Chief Legal Officer | Sale | 14.3K | $16.66 | $237.6K |
| Jan 31, 2026 | Houte Hans Van | Chief Financial Officer | Sale | 3.7K | $16.60 | $60.8K |
| Jan 31, 2026 | Christine Ring | Chief Legal Officer | Sale | 4.4K | $16.60 | $73.4K |
| Jan 31, 2026 | Gwenn Hansen | Chief Scientific Officer | Sale | 4.9K | $16.60 | $81.2K |
| Jan 21, 2026 | Christine Ring | Chief Legal Officer | Sale | 3.8K | $18.42 | $69.3K |
| Dec 18, 2025 | Christine Ring | Chief Legal Officer | Sale | 3.8K | $17.90 | $67.3K |
| Nov 24, 2025 | Christine Ring | Chief Legal Officer | Sale | 37.6K | $17.07 | $641.7K |
| Nov 4, 2025 | Houte Hans Van | Chief Financial Officer | Sale | 6.3K | $12.56 | $78.9K |
| Oct 30, 2025 | Houte Hans Van | Chief Financial Officer | Sale | 3.1K | $12.80 | $40.1K |
| Oct 30, 2025 | Christine Ring | Chief Legal Officer | Sale | 3.6K | $12.80 | $46.6K |
| Oct 30, 2025 | Gwenn Hansen | Chief Scientific Officer | Sale | 4.1K | $12.80 | $52.3K |
| Aug 1, 2025 | Houte Hans Van | Chief Financial Officer | Sale | 5.4K | $11.03 | $59.6K |
| Jul 30, 2025 | Houte Hans Van | Chief Financial Officer | Sale | 4.3K | $12.01 | $51.7K |
Showing the 25 most recent of 137 Form 4 filings for Nurix Therapeutics, Inc..
Most active NRIX insiders
- Christine Ring58 filings
- Gwenn Hansen34 filings
- Houte Hans Van33 filings
- Pierre Beaurang7 filings
- Stefani Wolff5 filings
Ask anything about NRIX insider activity
Use Trabud's AI agent to query Nurix Therapeutics, Inc.'s Form 4 history in plain English — "Show me NRIX CEO purchases this year" or compare it against any other ticker.
Open the AI agentNRIX insider trading FAQ
Are Nurix Therapeutics, Inc. insiders buying or selling?
Across 137 SEC Form 4 filings, Nurix Therapeutics, Inc. (NRIX) insiders reported 0 open-market purchases totaling $0 and 137 sales totaling $12.8M. That is a net selling position of $12.8M.
How many insiders trade NRIX stock?
5 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Nurix Therapeutics, Inc.. The most recent filing was accepted on Jul 2, 2026.
Where does Trabud get NRIX insider trading data?
All NRIX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.